Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL)

Autor: Zhang, Yuchen, Zou, Qihua, Zhao, Baitian, Su, Ning, Li, Zhihua, Wang, Xicheng, Liu, Panpan, Tian, Xiaopeng, Fang, Xiaojie, Cai, Jun, Li, Lirong, Liu, Yingxian, Xia, Yi, Cai, Qingqing
Zdroj: In Cell Reports Medicine 17 December 2024 5(12)
Databáze: ScienceDirect